Clinical Trial Update: Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an aspirin-free strategy using ticagrelor in patients with myocardial infarction treated medically, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Montreal Heart Institute | Conditions: NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI) | Phase 3 | Status: RECRUITING